[2.5 mg versus 5 mg neostigmine for reversal of pancuronium bromide].
D000328:Adult; D000368:Aged; D000769:Anesthesia, Inhalation; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010197:Pancuronium / Q000037:antagonists & inhibitors; D009435:Synaptic Transmission / Q000187:drug effects*
D009388:Neostigmine; D010197:Pancuronium
Neostigmin 2.5 mg versus 5 mg til reversering av pancuroniumbromid.